IO Biotech
IOBT
IOBT
19 hedge funds and large institutions have $24.8M invested in IO Biotech in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
19% less capital invested
Capital invested by funds: $30.6M → $24.8M (-$5.86M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$241K | |
| 2 | +$110K | |
| 3 | +$78.8K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$63K |
| 5 |
Two Sigma Investments
New York
|
+$31.5K |
Top Sellers
| 1 | -$1.81M | |
| 2 | -$1.13M | |
| 3 | -$368K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$102K |
| 5 |
Renaissance Technologies
New York
|
-$88K |